
Ensign Peak Advisors’s IDEAYA Biosciences IDYA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.6M | Buy |
741,833
+414,189
| +126% | +$8.71M | 0.03% | 372 |
|
2025
Q1 | $5.37M | Sell |
327,644
-236,573
| -42% | -$3.88M | 0.01% | 614 |
|
2024
Q4 | $14.5M | Sell |
564,217
-47,597
| -8% | -$1.22M | 0.03% | 382 |
|
2024
Q3 | $19.4M | Buy |
611,814
+128,100
| +26% | +$4.06M | 0.03% | 333 |
|
2024
Q2 | $17M | Sell |
483,714
-4,656
| -1% | -$163K | 0.03% | 336 |
|
2024
Q1 | $21.4M | Sell |
488,370
-1,669
| -0.3% | -$73.2K | 0.04% | 312 |
|
2023
Q4 | $17.4M | Buy |
490,039
+126,255
| +35% | +$4.49M | 0.03% | 321 |
|
2023
Q3 | $9.81M | Buy |
363,784
+130,350
| +56% | +$3.52M | 0.02% | 396 |
|
2023
Q2 | $5.49M | Buy |
233,434
+141,023
| +153% | +$3.31M | 0.01% | 559 |
|
2023
Q1 | $1.27M | Hold |
92,411
| – | – | ﹤0.01% | 1059 |
|
2022
Q4 | $1.68M | Sell |
92,411
-7,760
| -8% | -$141K | ﹤0.01% | 880 |
|
2022
Q3 | $1.5M | Buy |
100,171
+5,390
| +6% | +$80.4K | ﹤0.01% | 890 |
|
2022
Q2 | $1.31M | Hold |
94,781
| – | – | ﹤0.01% | 995 |
|
2022
Q1 | $1.06M | Buy |
94,781
+2,370
| +3% | +$26.5K | ﹤0.01% | 1164 |
|
2021
Q4 | $2.19M | Buy |
92,411
+55,496
| +150% | +$1.31M | ﹤0.01% | 925 |
|
2021
Q3 | $941K | Hold |
36,915
| – | – | ﹤0.01% | 1459 |
|
2021
Q2 | $775K | Hold |
36,915
| – | – | ﹤0.01% | 1500 |
|
2021
Q1 | $868K | Hold |
36,915
| – | – | ﹤0.01% | 1467 |
|
2020
Q4 | $517K | Hold |
36,915
| – | – | ﹤0.01% | 1598 |
|
2020
Q3 | $464K | Buy |
+36,915
| New | +$464K | ﹤0.01% | 1548 |
|